Thu.Jul 25, 2024

article thumbnail

New study shows at-home colon cancer screening test reduces risk of colorectal cancer death, as effective as screening colonoscopy

Science Daily: Pharmacology News

A noninvasive colorectal cancer screening test that can be done at home could reduce the risk of colorectal cancer death by 33%, according to a new study.

359
359
article thumbnail

Bird Flu Is Now Transmitting Mammal-to-Mammal: Study

Drugs.com

THURSDAY, July 25, 2024 -- The bird flu is now jumping between species of mammals, a step that draws the virus closer to hopping into human beings, a new study warns.Researchers have tracked transmission of avian influenza between dairy cows in.

Virus 290
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New drug shows promise in clearing HIV from brain

Science Daily: Pharmacology News

An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study. By targeting infected cells in the brain, drug may clear virus from hidden areas that have been a major challenge in HIV treatment.

Virus 356
article thumbnail

'Two-Target' Antibiotics Could Make Bacterial Resistance Much Tougher

Drugs.com

THURSDAY, July 25, 2025 -- Synthetic antibiotics that attack bacteria in two directions at once could be the solution for combatting antimicrobial-resistant bugs, a new study claims.These dual-action antibiotics, called macrolones, disrupt.

290
290
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

A recipe for zero-emissions fuel: Soda cans, seawater, and caffeine

Science Daily: Pharmacology News

Engineers discovered that when the aluminum in soda cans is purified and mixed with seawater, the solution produces hydrogen -- which can power an engine or fuel cell without generating carbon emissions. The reaction can be sped up by adding caffeine.

More Trending

article thumbnail

Spin qubits go trampolining

Science Daily: Pharmacology News

Researchers have developed somersaulting spin qubits for universal quantum logic. This achievement may enable efficient control of large semiconductor qubit arrays. The research group recently published their demonstration of hopping spins and somersaulting spins.

Research 328
article thumbnail

Need a Good Medicare Advantage Plan? They're Tough to Find for Poorer Americans

Drugs.com

THURSDAY, July 25, 2024 -- Medicare Advantage plans are touted as a great alternative to traditional Medicare, offering seniors easier access to doctors, hospitals and prescription drugs.But access to a good Medicare Advantage plan relies heavily.

Doctors 263
article thumbnail

How evolution tamed a deadly virus and why we should still worry

Science Daily: Pharmacology News

Over the last century, a once-deadly mosquito-borne virus has evolved so that it no longer sickens humans. New research shows that changes in the virus's ability to target human cells paralleled the decline in illness and death. The findings offer important lessons in virology that may help guide better preparedness for future outbreaks of other viral diseases.

Virus 323
article thumbnail

Dengue May Be Bigger Threat to Obese Children

Drugs.com

THURSDAY, July 25, 2024 -- Obese kids infected with dengue are significantly more likely to suffer severe illness requiring hospitalization, a new study warns.A new analysis of nearly 5,000 dengue-infected Sri Lankan children found that weight.

Hospitals 263
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

New Zealand's flightless birds are retreating to moa refuges

Science Daily: Pharmacology News

Researchers have found New Zealand's endangered flightless birds are seeking refuge in the locations where six species of moa last lived before going extinct.

Research 302
article thumbnail

Pesticides Can Equal Smoking in Hiking Risks for Cancer

Drugs.com

THURSDAY, July 25, 2024 -- Farmers and folks living in agricultural areas may be exposed to levels of pesticides that confer cancer risks that are higher than if they smoked, new research shows.These extra risks were most pronounced for certain.

Research 259
article thumbnail

Nitrogen emissions have a net cooling effect: But researchers warn against a climate solution

Science Daily: Pharmacology News

An international team of researchers has found that nitrogen emissions from fertilizers and fossil fuels have a net cooling effect on the climate. But they warn increasing atmospheric nitrogen has further damaging effects on the environment, calling for an urgent reduction in greenhouse gas emissions to halt global warming.

Research 296
article thumbnail

CDD Vault Update (July 2024)

Collaborative Drug

Inventory Search Interface: The new CDD Vault Inventory tab can be enabled by the CDD Support Team. If you wish to enable this tab in your vault please have your vault administrator contact support@collaborativedrug.com.

259
259
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Chemical analyses find hidden elements from renaissance astronomer Tycho Brahe's alchemy laboratory

Science Daily: Pharmacology News

Danish Tycho Brahe was most famous for his contributions to astronomy. However, he also had a well-equipped alchemical laboratory where he produced secret medicines for Europe's elite.

article thumbnail

New Insights Into How Sleep Apnea Affects the Brain

Drugs.com

THURSDAY, July 24, 2024 -- Millions of Americans deal with the sleep deficits brought on by sleep apnea, and many turn to one of the few treatments out there, continuous positive airway pressure (CPAP) machines.But what if new neurochemical targets.

Treatment 258
article thumbnail

NASA's Fermi finds new feature in brightest gamma-ray burst yet seen

Science Daily: Pharmacology News

In October 2022, astronomers were stunned by what was quickly dubbed the BOAT -- the brightest-of-all-time gamma-ray burst (GRB). Now an international science team reports that data from NASA's Fermi Gamma-ray Space Telescope reveals a feature never seen before.

article thumbnail

Where Your Body Stores Fat Could Affect Odds for Parkinson's, Alzheimer's

Drugs.com

THURSDAY, July 25, 2024 -- Finding yourself packing on the pounds around your waist and arms? If so, you might be at heightened risk for neurological illnesses like Alzheimer's or Parkinson's, new research suggests.There was one other physical.

Research 246
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Rock art and archaeological record reveal man's complex relationship with Amazonian animals

Science Daily: Pharmacology News

Rock art explored by archaeologists in the Colombian Amazon has provided an insight into the complex relationship between the earliest settlers on the continent and the animals they encountered.

239
239
article thumbnail

Wildfires in Western U.S., Canada Create Hazardous Air Conditions

Drugs.com

THURSDAY, July 25, 2024 -- Wildfires raging in several states and Canada are triggering air quality alerts and evacuation orders across the western parts of the United States.Smoke and haze have filled the skies in California, Oregon, Arizona.

246
246
article thumbnail

Ancient marine animal had inventive past despite being represented by few species

Science Daily: Pharmacology News

Brachiopods were evolving in new directions but this did not turn into evolutionary success in terms of the numbers of species, researchers have found.

Research 235
article thumbnail

U.S. Infant Deaths Rise for First Time in Decades

Drugs.com

THURSDAY, June 25, 2024 -- For the first time in two decades, the infant mortality rate in the United States has risen, new government data shows.In a report released Thursday by the U.S. Centers for Disease Control and Prevention, researchers.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Structural Dynamics of the Ubiquitin Specific Protease USP30 in Complex with a Cyanopyrrolidine-Containing Covalent Inhibitor

Covalent Modifiers

Darragh P O’Brien, Hannah BL Jones, Yuqi Shi, Franziska Guenther, Iolanda Vendrell, Rosa Viner, Paul E Brennan, Emma Mead, Tryfon Zarganes-Tzitzikas, John B Davis, Adán Pinto-Fernández, Katherine S England, Emma J Murphy, Andrew P Turnbull, Benedikt M Kessler bioRxiv 2024.07.20.604388; doi: [link] Inhibition of the mitochondrial deubiquitinating enzyme USP30 is neuroprotective and presents therapeutic opportunities for the treatment of idiopathic Parkinson’s Disease and mitophagy-related disorde

article thumbnail

Warming has more impact than cooling on Greenland's 'firn'

Science Daily: Pharmacology News

A new study finds disproportionate effects of temperature shifts on an icy glacier layer.

180
180
article thumbnail

Roche says it’ll move quickly with ‘differentiated’ obesity drugs

BioPharma Drive: Drug Pricing

CEO Thomas Schinecker claimed the company has “many opportunities” to stand out in the competitive field, and can get to market “much faster” than investors expect.

Marketing 171
article thumbnail

Is There a Peak Performance Age for Olympians?

Drugs.com

THURSDAY, July 25, 2024 -- The Olympics are often described as a rare, once-in-a-lifetime shot at international sports glory.That may be more true for Olympic track and field competitors than other athletes, a new study reports.There appears to be.

article thumbnail

Viking shares jump on plans to speed obesity drug into late-stage testing

BioPharma Drive: Drug Pricing

The drug’s advancement continued what one analyst described as a “torrid” pace for Viking’s closely watched medicine, which started human testing in 2022 and could reach a Phase 3 trial next year.

Drugs 171